SONRIANT, created in 2006 (Japan), from 440 sister brands and 4958 competing brands. SONRIANT is owned by Takeda Pharmaceutical, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. The sector of SONRIANT is Drug Manufacturers.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(SONRIANT)
over 5 years*
EUR 18.15